메뉴 건너뛰기




Volumn 197, Issue 2, 1998, Pages 101-108

Cutaneous mastocytosis in adults. Evaluation of 14 patients with respect to systemic disease manifestations

Author keywords

Cutaneous mastocytosis; Management; Prognosis; Systemic manifestations

Indexed keywords

ALPHA INTERFERON; CROMOGLYCATE DISODIUM; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; KETOTIFEN; PSORALEN;

EID: 0031854543     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017978     Document Type: Article
Times cited : (73)

References (37)
  • 1
    • 0025921178 scopus 로고
    • Classification and diagnosis of mastocytosis: Current status
    • Metcalfe DD: Classification and diagnosis of mastocytosis: Current status. J Invest Dermatol 1991;96(suppl):25-45.
    • (1991) J Invest Dermatol , vol.96 , Issue.SUPPL. , pp. 25-45
    • Metcalfe, D.D.1
  • 2
    • 0026073372 scopus 로고
    • Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
    • Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146: 1410-1415.
    • (1991) J Immunol , vol.146 , pp. 1410-1415
    • Kirshenbaum, A.S.1    Kessler, S.W.2    Goff, J.P.3    Metcalfe, D.D.4
  • 5
    • 0025242472 scopus 로고
    • Mast cells as a source of multifunctional cytokines
    • Gordon JR, Burd PR, Galli SJ: Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-464.
    • (1990) Immunol Today , vol.11 , pp. 458-464
    • Gordon, J.R.1    Burd, P.R.2    Galli, S.J.3
  • 6
    • 0025332846 scopus 로고
    • Mast cells as a source of both performed and immunologically inducible TNF-α/cachectin
    • Gordon JR, Galli SJ: Mast cells as a source of both performed and immunologically inducible TNF-α/cachectin. Nature 1990;346: 274-276.
    • (1990) Nature , vol.346 , pp. 274-276
    • Gordon, J.R.1    Galli, S.J.2
  • 8
    • 0021268981 scopus 로고
    • Cutaneous mastocytosis without clinically obvious skin lesions
    • Kendall ME, Fields JR, King LE Jr: Cutaneous mastocytosis without clinically obvious skin lesions. J Am Acad Dermatol 1984;10: 903-905.
    • (1984) J am Acad Dermatol , vol.10 , pp. 903-905
    • Kendall, M.E.1    Fields, J.R.2    King Jr., L.E.3
  • 9
    • 0025922016 scopus 로고
    • Conclusion: Clinical advances in mastocytosis: An interdisciplinary round table discussion
    • Metcalfe DD: Conclusion: Clinical advances in mastocytosis: An interdisciplinary round table discussion. J Invest Dermatol 1991;96 (suppl):64-65.
    • (1991) J Invest Dermatol , vol.96 , Issue.SUPPL. , pp. 64-65
    • Metcalfe, D.D.1
  • 10
    • 0024271215 scopus 로고
    • Systemic mast cell disease: Analysis of 58 cases and review of the literature
    • Travis WD, Li CY, Bergstrahl EJ, Yam LT, Swee RG: Systemic mast cell disease: Analysis of 58 cases and review of the literature. Medicine 1988;67:345-368.
    • (1988) Medicine , vol.67 , pp. 345-368
    • Travis, W.D.1    Li, C.Y.2    Bergstrahl, E.J.3    Yam, L.T.4    Swee, R.G.5
  • 13
    • 0028856070 scopus 로고
    • Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
    • Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci 1995; 92:10560-10564.
    • (1995) Proc Natl Acad Sci , vol.92 , pp. 10560-10564
    • Nagata, H.1    Worobec, A.S.2    Oh, C.K.3    Chowdhury, B.A.4    Tannenbaum, S.5    Suzuki, Y.6    Metcalfe, D.D.7
  • 14
    • 0009013631 scopus 로고    scopus 로고
    • Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
    • Longley BJ, Tyrrell L. Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-314.
    • (1996) Nat Genet , vol.12 , pp. 312-314
    • Longley, B.J.1    Tyrrell, L.2    Lu, S.Z.3    Ma, Y.S.4    Langley, K.5    Ding, T.G.6    Duffy, T.7    Jacobs, P.8    Tang, L.H.9    Modlin, I.10
  • 16
    • 0030998028 scopus 로고    scopus 로고
    • Chronically KIT-stimulated clonally derived human mast cells show heterogeneity in different tissue microenvironments
    • Longley BJ, Tyrell L, Lu S, Ma Y, Klump V, Murphy GF: Chronically KIT-stimulated clonally derived human mast cells show heterogeneity in different tissue microenvironments. J Invest Dermatol 1997;108:792-796.
    • (1997) J Invest Dermatol , vol.108 , pp. 792-796
    • Longley, B.J.1    Tyrell, L.2    Lu, S.3    Ma, Y.4    Klump, V.5    Murphy, G.F.6
  • 17
  • 20
    • 0023907495 scopus 로고
    • Carcinoid syndrome and disorders of mast cell activation including systemic mastocytosis
    • Roberts LJ II: Carcinoid syndrome and disorders of mast cell activation including systemic mastocytosis. Endocrinol Metab Clin North Am 1988;17:415-436.
    • (1988) Endocrinol Metab Clin North am , vol.17 , pp. 415-436
    • Roberts Jr., L.J.1
  • 21
    • 0023695019 scopus 로고
    • Significance of associated mast cell disease with associated hematologic disorders
    • Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG: Significance of associated mast cell disease with associated hematologic disorders. Cancer 1988;62:965-972.
    • (1988) Cancer , vol.62 , pp. 965-972
    • Travis, W.D.1    Li, C.Y.2    Yam, L.T.3    Bergstralh, E.J.4    Swee, R.G.5
  • 22
  • 24
    • 0029067610 scopus 로고
    • Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2
    • Morrow JD, Guzzo C, Lazerus G, Oates JA, Jackson Roberts L II: Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2. J Invest Dermatol 1995;104:937-940.
    • (1995) J Invest Dermatol , vol.104 , pp. 937-940
    • Morrow, J.D.1    Guzzo, C.2    Lazerus, G.3    Oates, J.A.4    Jackson Roberts II, L.5
  • 25
    • 0025921183 scopus 로고
    • The treatment of mastocytosis: An overview
    • Metcalfe DD: The treatment of mastocytosis: An overview. J Invest Dermatol 1991;96(suppl): 55-56.
    • (1991) J Invest Dermatol , vol.96 , Issue.SUPPL. , pp. 55-56
    • Metcalfe, D.D.1
  • 26
    • 0018687287 scopus 로고
    • Oral disodium cromoglycate in the treatment of systemic mastocytosis
    • Soter NA, Austen KF, Wassermann SI: Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301: 465-469.
    • (1979) N Engl J Med , vol.301 , pp. 465-469
    • Soter, N.A.1    Austen, K.F.2    Wassermann, S.I.3
  • 27
    • 0021907622 scopus 로고
    • Comparison of the therapeutic efficiency of cromolyn disodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis
    • Frieri M, Ailing DW, Metcalfe DD: Comparison of the therapeutic efficiency of cromolyn disodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Am J Med 1985;78:9-14.
    • (1985) Am J Med , vol.78 , pp. 9-14
    • Frieri, M.1    Ailing, D.W.2    Metcalfe, D.D.3
  • 28
    • 0021237539 scopus 로고
    • Response of cutaneous mast cell to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations
    • Kolde G, Frosch PJ, Czarnetzki BM: Response of cutaneous mast cell to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations. J Invest Dermatol 1984;83:75-78.
    • (1984) J Invest Dermatol , vol.83 , pp. 75-78
    • Kolde, G.1    Frosch, P.J.2    Czarnetzki, B.M.3
  • 30
    • 0020660043 scopus 로고
    • A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa
    • Czarnetzki BM: A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 1983;166:44-47.
    • (1983) Dermatologica , vol.166 , pp. 44-47
    • Czarnetzki, B.M.1
  • 32
    • 0029013848 scopus 로고
    • Treatment of urticaria pigmentosa using interferon alpha
    • Kolde G, Sunderkötter C, Luger T: Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol 1995;133:91-94.
    • (1995) Br J Dermatol , vol.133 , pp. 91-94
    • Kolde, G.1    Sunderkötter, C.2    Luger, T.3
  • 33
    • 0029097623 scopus 로고
    • Treatment of systemic mastocytosis with interferon-γ: Failure after appearance of anti-IFN-γ antibodies
    • Fiehn C, Prümmer O, Gallati H, Heilig B, Hunstein W: Treatment of systemic mastocytosis with interferon-γ: Failure after appearance of anti-IFN-γ antibodies. Eur J Clin Invest 1995; 25:615-618.
    • (1995) Eur J Clin Invest , vol.25 , pp. 615-618
    • Fiehn, C.1    Prümmer, O.2    Gallati, H.3    Heilig, B.4    Hunstein, W.5
  • 34
    • 0028912332 scopus 로고
    • Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alfa therapy
    • Petit A, Pulik M, Gaulier A, Lionnet F, Mahe A, Sigal M: Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alfa therapy. J Am Acad Dermatol 1995;32: 850-853.
    • (1995) J am Acad Dermatol , vol.32 , pp. 850-853
    • Petit, A.1    Pulik, M.2    Gaulier, A.3    Lionnet, F.4    Mahe, A.5    Sigal, M.6
  • 37
    • 0025780558 scopus 로고
    • Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon
    • Pardini S, Bosincu L, Bonfigli S, Dore F, Longinotti M: Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon. Acta Haematol 1991;85:220.
    • (1991) Acta Haematol , vol.85 , pp. 220
    • Pardini, S.1    Bosincu, L.2    Bonfigli, S.3    Dore, F.4    Longinotti, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.